BDSI BioDelivery Sciences International Inc

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions today announced that Herm Cukier, Chief Executive Officer will present at the following investor conferences:

• Jefferies 2019 Healthcare Conference on Tuesday, June 4, 2019, at 4:00 PM ET 
• William Blair 39th Annual Growth Stock Conference on Wednesday, June 5, 2019, at 10:40 AM CT

The sessions may be accessed from the "Investors" page of BDSI’s website at https://bdsi.com.  Replays of the presentation will be archived on the Company's website and made available for 60 days.

ABOUT BIODELIVERY SCIENCES INTERNATIONAL, INC.

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products and those in development address serious and debilitating conditions such as chronic pain, breakthrough cancer pain, opioid dependence, and opioid-induced constipation.

Contact:

Mary ColemanVice President, Investor Relations and Corporate CommunicationsBioDelivery Sciences International, Inc.mcoleman@bdsi.com